Eric Greig

Eric advises clients on healthcare regulatory matters, market access strategies and reimbursement issues across the medical device, pharmaceutical, digital health, biotechnology, diagnostics and healthcare services sectors. Eric leverages his successful track record in bet-the-company regulatory matters, as well as his extensive experience with health payment systems and innovative solutions, to counsel clients across the healthcare and life sciences industry.

His experience includes:

* Development and execution of market access strategies for new and existing technologies

* Advocacy with Congress and federal and state agencies, including the Centers for Medicare & Medicaid Services (CMS)

* Medicare, Medicaid and commercial insurer coverage, coding and reimbursement matters

* Federal and state fraud and abuse laws, including analysis of innovative and value-based arrangements and development of compliance programs

* Compliance with billing policies and responses to payor audits

* Federal and state physician payment and pricing transparency laws

* Complex litigation matters, including government audits and investigations, qui tam lawsuits and other matters involving the Health and Human Services (HHS) Office of Inspector General (OIG), US Department of Justice (DOJ) and CMS Center for Program Integrity

Eric also advises private equity firms, investment banks, venture capital funds, commercial lenders, and healthcare and life sciences companies on regulatory issues related to mergers and acquisitions, capital markets transactions and US financings.

Eric is a member of the American Health Law Association and the American Bar Association Health Law Section.

A recognized thought leader, Eric regularly writes and speaks on healthcare and life sciences topics. He co-authored a chapter related to Medicare and Medicaid reimbursement for off-label uses of drugs and devices in “Off-Label Communications: A Guide to Sales & Marketing Compliance,” published by the Food and Drug Law Institute, and he presents on healthcare regulatory and reimbursement topics at national conferences organized by leading industry organizations – including AdvaMed, PhRMA, the American Health Law Association, the Medical Device Manufacturers Association, the 8400 Health Network and the California Life Sciences Institute.